Literature DB >> 30766201

The Cost of Oncology Drugs: A Pharmacy Perspective, Part I.

Brian J Dahl1.   

Abstract

Even in the VA, the high cost of oncology medications are forcing health care providers to confront the economic impact of cancer care.

Entities:  

Year:  2016        PMID： 30766201      PMCID： PMC6375405     

Source DB:  PubMed          Journal:  Fed Pract        ISSN： 1078-4497


  2 in total

1.  A New Methodology to Estimate Drug Cost Avoidance in Clinical Trials: Development and Application.

Authors:  Sebastián García-Sánchez; Roberto Collado-Borrell; Eva González-Haba; José Luis Revuelta-Herrero; Vicente Escudero-Vilaplana; María Belén Marzal-Alfaro; María Norberta Sánchez-Fresneda; Ana Mur-Mur; Ana Herranz; Miguel Martín; María Sanjurjo
Journal:  Front Oncol       Date:  2022-06-08       Impact factor: 5.738

Review 2.  Microbiome as a Target for Cancer Therapy.

Authors:  Ratoe Suraya; Tatsuya Nagano; Kazuyuki Kobayashi; Yoshihiro Nishimura
Journal:  Integr Cancer Ther       Date:  2020 Jan-Dec       Impact factor: 3.279
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.